Quality-by-design model in optimization of PEG-PLGA nano micelles for targeted cancer therapy
Authors:
- Zahra EskandariZEZahra Eskandari
- Fatma KazdalFKFatma Kazdal
- Fatemeh BahadoriFBFatemeh Bahadori
- Nabiallah EbrahimiNENabiallah Ebrahimi
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 48, 393-402
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- A critical review about methodologies for the analysis of mucoadhesive properties of drug delivery systemsDrug Development and Industrial Pharmacy, 2017
- PLGA: a Unique Polymer for Drug DeliveryTherapeutic Delivery, 2015
- A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell lineArtificial Cells, Nanomedicine, and Biotechnology, 2014
- Drug delivery systems: An updated reviewInternational Journal of Pharmaceutical Investigation, 2012
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery CarrierPolymers, 2011
- Importance of novel drug delivery systems in herbal medicinesPharmacognosy Reviews, 2010
- Nanoparticle-based targeted drug deliveryExperimental and Molecular Pathology, 2009
- PLGA-based drug delivery systems: Importance of the type of drug and device geometryInternational Journal of Pharmaceutics, 2008
- Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA–PEG block copolymersJournal of Controlled Release, 2003
- Drug delivery systemsAmerican Journal of Health-System Pharmacy, 1991